CCIA
Campbell & Co Investment Adviser’s Alnylam Pharmaceuticals ALNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-16,858
| Closed | -$3.97M | – | 1008 |
|
|
2024
Q4 | $3.97M | Buy |
+16,858
| New | +$3.97M | 0.31% | 66 |
|
|
2024
Q2 | – | Sell |
-10,614
| Closed | -$1.59M | – | 1030 |
|
|
2024
Q1 | $1.59M | Sell |
10,614
-12,757
| -55% | -$1.91M | 0.14% | 221 |
|
|
2023
Q4 | $4.47M | Buy |
+23,371
| New | +$4.47M | 0.4% | 15 |
|
|
2022
Q4 | – | Sell |
-2,558
| Closed | -$512K | – | 752 |
|
|
2022
Q3 | $512K | Sell |
2,558
-2,983
| -54% | -$597K | 0.12% | 307 |
|
|
2022
Q2 | $808K | Buy |
5,541
+2,689
| +94% | +$392K | 0.22% | 127 |
|
|
2022
Q1 | $466K | Buy |
+2,852
| New | +$466K | 0.13% | 303 |
|
|
2021
Q4 | – | Sell |
-1,300
| Closed | -$245K | – | 603 |
|
|
2021
Q3 | $245K | Buy |
+1,300
| New | +$245K | 0.08% | 447 |
|
|
2018
Q3 | – | Sell |
-2,703
| Closed | -$266K | – | 391 |
|
|
2018
Q2 | $266K | Buy |
+2,703
| New | +$266K | 0.2% | 235 |
|
|
2015
Q1 | – | Sell |
-6,652
| Closed | -$645K | – | 193 |
|
|
2014
Q4 | $645K | Buy |
+6,652
| New | +$645K | 0.4% | 96 |
|